Is SHED itself FDA-approved?

No, and that's not quite the right question. The FDA approves medicines, not telehealth platforms. SHED is a telehealth company that prescribes both FDA-approved medicines (Foundayo, Wegovy pill, Wegovy pen, Zepbound vial) and compounded medicines (which by definition are not FDA-approved). The accurate question is whether the specific SHED medicine you're considering is FDA-approved — and the product matrix on this page answers that.

Does SHED offer Zepbound?

Yes. SHED currently lists Zepbound as an FDA-approved chronic weight-management option, with access to Zepbound in vial form when clinically approved. That's separate from SHED's compounded tirzepatide lane. Note that SHED's Zepbound pathway specifically lists vial access — not the Zepbound pen or Zepbound KwikPen formats. If you want the pen or KwikPen specifically, Ro is currently the more direct path.

Is compounded semaglutide FDA-approved?

No. By definition, compounded medicines aren't FDA-approved. The FDA's premarket review process applies to brand-name finished drug products like Wegovy and Ozempic. Compounded semaglutide is custom-prepared by a licensed pharmacy under a prescriber's order and doesn't go through that review. The FDA's own position is that compounded drugs should only be used when a patient's medical needs cannot be met by an FDA-approved drug.

Is SHED's compounded semaglutide the same as Ozempic or Wegovy?

No. Compounded semaglutide is prepared separately by compounding pharmacies and is not the same finished product as Ozempic or Wegovy. The FDA has specifically warned companies not to market compounded GLP-1s as generics or as "the same" as the FDA-approved drugs — they are different regulatory categories of medicine.

Are SHED GLP-1 lozenges FDA-approved?

No. The lozenges are compounded sublingual semaglutide and are not FDA-approved. The only FDA-approved oral semaglutide products are Rybelsus and the Wegovy pill, both of which went through specific clinical trials to establish absorption and efficacy. Compounded oral options have not been tested the same way.

Does SHED offer FDA-approved medications?

Yes. SHED currently lists FDA-approved Foundayo, Wegovy pill, Wegovy pen, and Zepbound (vial) through its brand-name pathway. Medicine is filled through LillyDirect or NovoCare. SHED's brand-name pathway is separate from its compounded program.

Can I use insurance with SHED?

Partially. The Shed Membership/provider fee is paid directly to SHED and is not covered by insurance. For FDA-approved brand-name GLP-1s (Foundayo, Wegovy, Zepbound vial), insurance may cover the medication through the dispensing pharmacy (LillyDirect or NovoCare) — verify with your insurer before committing. Compounded GLP-1s on SHED are cash-pay. HSA/FSA cards can be used for eligible prescription medication purchases.

Is SHED GLP-1 FDA Approved? Compounded vs Brand-Name (2026)

By WPG Research TeamPublished May 16, 2026Updated May 16, 2026

Last verified: May 16, 2026 by the Weight Loss Provider Guide editorial team. We checked SHED’s product pages, SHED’s help center, FDA primary sources, LillyDirect, NovoCare, Trustpilot, the BBB, and Ro’s current pricing page.

Affiliate disclosure: We may earn a commission if you sign up with a provider through our links. That does not change the FDA-status answer, the pricing notes, or the drawbacks we share below. Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers.

Is SHED GLP-1 FDA approved? The honest answer

Is SHED GLP-1 FDA approved? It depends on which SHED product you’re talking about — and that’s the part most pages miss.

SHED itself is a telehealth platform, not a drug. The FDA approves medicines, not telehealth companies, so “is SHED FDA approved” is the wrong frame. The real question is: which SHED medicine are you looking at?

Here’s the honest split, verified as of May 16, 2026:

✅

FDA-approved options listed by SHED: Foundayo® (orforglipron), Wegovy® pill, Wegovy® pen, and Zepbound® (vial). SHED published its Foundayo pathway on April 14, 2026 — about two weeks after the FDA approved the drug. For all of these, SHED is the telehealth access point; the medicine itself comes from LillyDirect (Foundayo, Zepbound) or NovoCare (Wegovy).

❌

Not FDA-approved on SHED: Every compounded option. That includes compounded semaglutide injections, compounded tirzepatide injections, GLP-1 liquid drops, semaglutide lozenges, oral semaglutide liposomal tablets, and microdose programs. SHED states this on its own product pages: “Compounded medications are not FDA-approved.” The FDA agrees — compounded drugs do not go through FDA’s premarket review for safety, effectiveness, or quality.

The FDA’s own guidance is that compounded drugs should only be used when a patient’s medical needs cannot be met by an FDA-approved drug. Not counterfeit. Not illegal when prepared by a licensed pharmacy under a prescriber’s order. Just a different regulatory category than Wegovy, Zepbound, or Foundayo.

At a glance

What you mean by “SHED GLP-1”	FDA approved?	Your move
SHED’s compounded injections, drops, lozenges, or tablets	No — these are compounded medications	Read the compounded section below before deciding
SHED’s Foundayo, Wegovy pill, Wegovy pen, or Zepbound vial pathway	Yes — these are FDA-approved brand-name drugs	See SHED’s brand-name lane below
SHED the company itself	Not applicable — platforms aren’t FDA-approved	Look at the actual medicine, not the platform

Check your SHED eligibility Not sure which lane? Take the quiz →

Why this question is more complicated than it sounds

Answer capsule: “Is SHED FDA approved” mixes up three different things — the SHED platform, SHED’s compounded medicines, and SHED’s brand-name medicines. The FDA only approves the medicines, and SHED runs both compounded (not FDA-approved) and brand-name (FDA-approved) programs under one roof. The accurate answer depends on which lane your prescription goes through.

We get why people type this exact phrase. You probably saw a SHED ad. Or a friend mentioned the brand. Or you got mid-checkout, saw the line “compounded medications are not FDA-approved,” and paused. That’s a smart pause. Most people don’t pause there.

But “is SHED FDA approved” treats SHED like a single thing — and SHED isn’t a single thing. As of 2026, SHED runs two parallel programs:

The compounded program (where most SHED traffic still goes). Custom-mixed semaglutide and tirzepatide products made by licensed compounding pharmacies. Not FDA-approved.
The brand-name program. SHED currently lists Foundayo, Wegovy pill, Wegovy pen, and Zepbound (vial) access. The drugs themselves are FDA-approved and come from Eli Lilly’s or Novo Nordisk’s official distribution channels.

So when you ask “is SHED FDA approved,” the only honest answer is: which SHED? That distinction is the entire reason this page exists.

The full SHED FDA-status breakdown

Answer capsule: Four SHED products are FDA-approved brand-name medications: Foundayo, Wegovy pill, Wegovy pen, and Zepbound (vial). Every other SHED GLP-1 product is compounded and not FDA-approved. The table below shows the full lineup with sources and what each one means for you.

We built this matrix by visiting every SHED product page directly, checking SHED’s help center, and confirming FDA-approval status against FDA primary sources.

SHED product	Active ingredient	FDA status	Who makes / fills it	What it means for you
Foundayo® (orforglipron)	Orforglipron	✅ FDA-approved (Apr 1, 2026)	Eli Lilly; refills through LillyDirect	Same FDA-approved oral GLP-1 you’d get elsewhere. SHED is your telehealth access.
Wegovy® pill (oral semaglutide)	Semaglutide	✅ FDA-approved	Novo Nordisk; refills through NovoCare	FDA-approved oral semaglutide. SHED is the access route, not the pharmacy.
Wegovy® pen (injectable semaglutide)	Semaglutide	✅ FDA-approved	Novo Nordisk; refills through NovoCare	FDA-approved weekly injection. Same drug as any pharmacy.
Zepbound® (vial)	Tirzepatide	✅ FDA-approved	Eli Lilly; fulfilled through LillyDirect channel	Vial format only. Not the Zepbound pen or KwikPen format.
GLP-1 Injections (compounded)	Compounded semaglutide or tirzepatide	❌ Not FDA-approved	Licensed compounding pharmacy	Custom-mixed at a licensed pharmacy. Not reviewed by FDA for safety, effectiveness, or quality.
GLP-1 Liquid Drops	Compounded semaglutide	❌ Not FDA-approved	Licensed compounding pharmacy	Oral compounded format. Absorption not clinically established the way the Wegovy pill was.
Semaglutide Lozenges	Compounded semaglutide	❌ Not FDA-approved	Licensed compounding pharmacy	Sublingual (under the tongue) compounded format. Same absorption questions as drops.
Oral Semaglutide Liposomal Tablets	Compounded semaglutide	❌ Not FDA-approved	Licensed compounding pharmacy	Compounded oral tablet. Not an FDA-approved GLP-1 drug product.
Microdose GLP-1	Compounded semaglutide or tirzepatide at low doses	❌ Not FDA-approved	Licensed compounding pharmacy	Marketed for “wellness.” Limited clinical evidence at sub-therapeutic doses for weight loss.

Sources: SHED’s own product pages and help center; FDA’s “Compounding and the FDA” Q&A; FDA’s “Concerns with Unapproved GLP-1 Drugs Used for Weight Loss” notice; Eli Lilly’s Foundayo announcement (April 14, 2026); Novo Nordisk’s Wegovy approvals.

Update most other sites haven’t caught: SHED added Foundayo on April 14, 2026 — and SHED also currently lists Zepbound vial access alongside its existing Wegovy and compounded options. Older ShedRx review pages that describe SHED as compounded-only are stale.

Start your SHED visit — see which lane you qualify for

What “compounded” actually means (in plain English)

Answer capsule: A compounded drug is a custom medicine made by a licensed pharmacy for a specific patient based on a prescription. Compounded drugs are not FDA-approved — the FDA didn’t review that specific medicine for safety, quality, or effectiveness before it was made. Compounded is not the same as counterfeit, and it’s not the same as a generic.

When the FDA “approves” a drug — like Wegovy or Zepbound — it means the drugmaker ran clinical trials with thousands of people, the FDA reviewed the data, and the FDA agreed the drug is safe and effective for a specific use at a specific dose. Every pen of Wegovy is the same as every other pen of Wegovy.

Compounded medicines work differently. A licensed pharmacy mixes the medicine for one patient at a time, based on what a doctor prescribed. The pharmacy is licensed and regulated by its state. But the FDA never reviewed that specific compounded medicine before it was made. That’s not a loophole — it’s how compounding works. It’s a real practice used for custom dosages, allergies to inactive ingredients, or shortage situations.

There are two main types of compounding pharmacies in the U.S.:

503A pharmacies are state-licensed and compound for individual patients based on individual prescriptions. They’re the most common type, and they’re the ones SHED’s compounded prescriptions typically go through.
503B outsourcing facilities compound at larger scale, must follow stricter manufacturing standards (cGMP), and supply clinics and hospitals as well as individual patients.

Neither type produces FDA-approved medicines. That word — “approved” — only applies to brand-name drugs that went through FDA’s premarket review.

Compounded is not a generic

A lot of marketing language blurs this. A generic drug is FDA-approved. Generic Lipitor is FDA-approved. Generic metformin is FDA-approved. Those went through FDA’s generic review process. There is no FDA-approved generic version of Wegovy or Zepbound right now.

So when someone tells you a compounded GLP-1 is “the same active ingredient as Wegovy” or “a generic version of Zepbound,” that language doesn’t hold up. The FDA has explicitly warned companies not to market compounded GLP-1s as generics or as “the same” as the FDA-approved drugs. We won’t tell you that either.

What’s true: compounded semaglutide and compounded tirzepatide use the same drug substance names as the FDA-approved versions. But the finished products are different categories of medicine, prepared in different ways, with different oversight.

The 2026 regulatory situation

Semaglutide and tirzepatide are no longer on the FDA’s drug shortage list (they came off in 2025), and the FDA’s shortage-based enforcement-discretion periods have ended.
On April 30, 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B Bulks List. If finalized, that would significantly restrict 503B outsourcing-facility compounding of these drugs from bulk drug substance.
The public comment period on that proposal runs through the end of June 2026.
503A pharmacies can still compound on a patient-specific basis when applicable federal and state compounding requirements are met. The Bulks List proposal doesn’t directly cover 503A.
The FDA has also said it has received adverse-event reports related to compounded semaglutide and tirzepatide, including events tied to dosing errors.

What this means in practice: SHED’s compounded prescriptions typically flow through 503A pharmacies under current rules. The regulatory environment is actively shifting. If long-term certainty matters to you, the FDA-approved lane is the steadier choice — and SHED offers that too (Foundayo, Wegovy pill, Wegovy pen, Zepbound vial).

Which SHED products ARE FDA-approved?

Answer capsule: Four: Foundayo (orforglipron), the Wegovy pill (oral semaglutide), the Wegovy pen (injectable semaglutide), and Zepbound (vial form, tirzepatide). All four are FDA-approved brand-name drugs manufactured by Eli Lilly or Novo Nordisk. SHED provides the telehealth visit; the medicine itself is filled through LillyDirect or NovoCare.

Foundayo® (orforglipron) on SHED

The FDA approved Foundayo on April 1, 2026 for chronic weight management. It’s Eli Lilly’s once-daily oral GLP-1 pill — no needles, no special meal timing.

SHED published its Foundayo pathway on April 14, 2026. Members complete a SHED visit; if approved, the prescription is filled through LillyDirect. Related: Best Foundayo providers that accept insurance.

Wegovy® pill on SHED

Novo Nordisk’s Wegovy pill is FDA-approved oral semaglutide for chronic weight management. SHED added access to this pathway in 2026. The SHED visit is your access point; refills go through NovoCare. SHED’s compounded oral semaglutide products (drops, lozenges, liposomal tablets) are not the same medicine.

Wegovy® pen on SHED

The Wegovy pen is the once-weekly injectable semaglutide. FDA-approved, manufactured by Novo Nordisk, filled through NovoCare after a SHED clinical visit.

Zepbound® (vial) on SHED

SHED’s Zepbound page lists access to Zepbound in vial form when clinically approved. Zepbound is Eli Lilly’s FDA-approved tirzepatide for chronic weight management. Note: vial format only — not the pen or KwikPen formats. Related: Foundayo vs Zepbound comparison.

In all four cases, SHED is your telehealth provider — not the pharmacy and not the manufacturer. The medicine itself comes from the manufacturer’s official pipeline. What SHED adds: the clinical relationship, care coordination, and the ability to switch between programs without changing platforms.

See if you qualify for SHED’s FDA-approved options

Which SHED products are NOT FDA-approved?

Answer capsule: Every compounded SHED product. That includes the compounded injections (semaglutide and tirzepatide), liquid drops, lozenges, liposomal tablets, and microdose programs. SHED states this on its own product pages. The medicines are prescribed by licensed providers and prepared by licensed compounding pharmacies, but the FDA has not reviewed them.

Compounded semaglutide and tirzepatide injections

These are SHED’s most common prescriptions. Injected weekly, similar in routine to Wegovy or Zepbound. But the FDA hasn’t reviewed the chemistry. The compounding pharmacy mixes the drug from drug substance ingredients, and quality control sits with the pharmacy — not the FDA.

Most people who choose this lane do it for cost reasons. Compounded GLP-1s on SHED start lower than FDA-approved brand-name cash prices. That’s a legitimate reason, but it comes with the trade-off that the FDA hasn’t vetted the specific product — and the FDA has received adverse-event reports tied to compounded semaglutide and tirzepatide, particularly around dosing errors.

GLP-1 liquid drops (oral semaglutide drops)

Liquid drops are taken under the tongue. Compounded oral semaglutide. Not FDA-approved.

The honest caveat: the only FDA-approved oral semaglutide products are Rybelsus and the Wegovy pill. Both required specific technology to overcome semaglutide’s poor oral absorption. Compounded oral semaglutide drops haven’t gone through clinical trials that prove the same absorption or weight-loss effect. If clinical evidence is what you want, the drops aren’t the strongest evidence base.

Semaglutide lozenges

Sublingual (under the tongue) compounded semaglutide. Not FDA-approved. Same absorption limitations as the drops — there are no published clinical trials establishing efficacy for this specific compounded delivery format.

Oral semaglutide liposomal tablets

Compounded oral tablet using liposomal technology. Not FDA-approved. Not the same medicine as the Wegovy pill, which uses Novo Nordisk’s SNAC absorption technology validated in clinical trials.

Microdose GLP-1

Compounded semaglutide or tirzepatide at low doses. Not FDA-approved. Marketed for “wellness.” Limited clinical evidence at sub-therapeutic doses for weight loss specifically.

Three clean next steps

If you understand the compounded lane and SHED fits your budget and preferences:

Start your SHED visit

Short telehealth visit, see what’s available in your state

If you want FDA-approved only and specifically want SHED:

See SHED’s FDA-approved options

Foundayo, Wegovy pill, Wegovy pen, or Zepbound vial through licensed providers

If you want the broadest FDA-approved menu plus insurance support:

See Ro’s full GLP-1 program

Foundayo, Wegovy pill, Wegovy pen, Zepbound pen, Zepbound KwikPen — $39 first month, then $149/mo, or as low as $74/mo on annual prepay

Still not sure which path fits?

Take our free 60-second GLP-1 matching quiz →

We’ll route you to the program that fits your state, priorities, and medical history

SHED’s two-month minimum — what you need to know

Two-month minimum. SHED requires at least two months on the compounded program before you can cancel.
72-hour cancellation window. To stop the next charge, cancel at least 72 hours before your next billing date.
No cancellation = next charge. Miss the window, the next month bills.
Early-cancellation exceptions exist for specific situations like adverse side effects or provider-directed discontinuation, with documentation.

This isn’t unique to SHED — most telehealth GLP-1 programs have some form of commitment period. But SHED’s is on the longer end.

The honest pivot: SHED is not the right choice if a flexible month-to-month subscription is non-negotiable for you.

If the two-month minimum is a dealbreaker for you: Ro’s Body program doesn’t carry a two-month compounded lock-in, gives you access to FDA-approved GLP-1s (Foundayo, Wegovy pill, Wegovy pen, Zepbound pen, Zepbound KwikPen), and includes dedicated insurance support.

See if Ro is the better fit Check your SHED eligibility now

Insurance, HSA, and FSA on SHED — what actually works

Answer capsule: SHED’s membership/provider fee is paid to SHED and isn’t billed to insurance. The medication itself, when it’s an FDA-approved brand-name drug, may have insurance or cash-pay options through the dispensing pharmacy (LillyDirect, NovoCare). HSA and FSA cards are accepted for eligible prescription medication purchases — but HSA/FSA eligibility is not FDA approval.

The Shed Membership / provider fee is your payment to SHED for the telehealth visit, ongoing provider access, and care coordination. SHED’s pages describe this as paid directly to SHED. Plan to cover that out-of-pocket.

The medication cost depends on the lane:

For compounded GLP-1s: Cash-pay. HSA/FSA cards can be used for the prescription medication purchase.
For brand-name FDA-approved GLP-1s (Foundayo, Wegovy pill, Wegovy pen, Zepbound vial): SHED’s brand-name pages reference “insurance or cash-pay options,” with the medication payment handled through the dispensing pharmacy (LillyDirect or NovoCare). Whether insurance covers your specific situation depends on your plan, the drug, and prior authorization — verify directly with the dispensing pharmacy and your insurer before committing.

One trap to avoid: HSA/FSA eligibility is not FDA approval. We’ve seen reviews online conflate the two. They’re separate. A compounded medicine can be HSA/FSA-eligible (because it’s a prescription) and still not be FDA-approved.

If insurance support is your priority — meaning you want someone fighting for your coverage on FDA-approved GLP-1s — Ro’s Body program has a dedicated insurance concierge that handles prior-authorization paperwork. Cash prices match LillyDirect, NovoCare, and TrumpRx.

See Ro’s GLP-1 program with insurance support

Is SHED legit?

Answer capsule: Yes — SHED is a legitimately operating telehealth company founded in 2022, based in Salt Lake City, reportedly serving more than 150,000 patients, and rated 4.7 stars from 955 reviews on Trustpilot. “Legitimate” is not the same as “FDA-approved,” and that distinction is where most confusion behind this exact search comes from.

✅ LegitScript certified

Independent screening service for telehealth platforms — not an FDA endorsement, but a real operational signal.

✅ Trustpilot: 4.7 / 955 reviews

Strong customer satisfaction signal as of May 2026.

⚠️ BBB: B rating (not accredited)

Not BBB accredited. B rating. Complaints follow the typical pattern for subscription telehealth companies.

✅ Licensed providers and pharmacies

SHED’s prescriptions are issued by licensed clinicians and filled by state-licensed compounding pharmacies or manufacturer-authorized channels.

“Legitimate” means SHED operates legally and has real clinical infrastructure. It does not mean every SHED product is FDA-approved — the product matrix above shows exactly which ones are and aren’t. For our deeper review, see: SHED GLP-1 reviews or Is SHED legit? (full breakdown).

Who SHED is best for

Profile 1

“I want the lowest possible cost for a compounded GLP-1 and I understand it’s not FDA-approved”

You’ve read this guide. You understand what compounded means. You want the compounded lane for budget reasons, and the regulatory trade-off is one you’re willing to make with your prescriber’s input.

Best fit: SHED’s compounded program.

Start your SHED visit

Profile 2

“I want FDA-approved only and I specifically want SHED”

You want Foundayo, the Wegovy pill, the Wegovy pen, or Zepbound vial — and you want SHED as your telehealth platform. That’s a completely valid choice. SHED’s brand-name pathway is a legitimate way to access these drugs.

Best fit: SHED’s FDA-approved lane.

See SHED’s FDA-approved options

Profile 3

“I want FDA-approved + insurance support + the broadest brand-name menu”

You want a plan to pay part of this, or someone to fight for your insurance coverage. You want every FDA-approved option on the table — including Zepbound pen and Zepbound KwikPen, which SHED’s brand-name pathway doesn’t currently include. You want the lowest cash-pay pricing matched to LillyDirect, NovoCare, and TrumpRx.

Best fit: Ro Body. $39 first month, then $149/month, or as low as $74/month with annual prepay. Dedicated insurance concierge included.

See Ro’s full FDA-approved GLP-1 lineup

SHED vs Ro: which is better for FDA-approved GLP-1?

Answer capsule: Both SHED and Ro give you FDA-approved GLP-1 options. SHED lists Foundayo, Wegovy pill, Wegovy pen, and Zepbound vial. Ro lists Foundayo, Wegovy pill, Wegovy pen, Zepbound pen, and Zepbound KwikPen, plus a dedicated insurance concierge. SHED is the better fit if you want optional compounded formats under the same account. Ro is the better fit if you want the broadest brand-name menu, insurance support, or the lowest cash-pay pricing locked in.

Feature	SHED (FDA-approved lane)	Ro Body
Foundayo®	✅	✅
Wegovy® pill	✅	✅
Wegovy® pen	✅	✅
Zepbound® vial	✅	Check current Ro options
Zepbound® pen	❌	✅
Zepbound® KwikPen	❌	✅
Dedicated insurance concierge	Limited	✅
Free insurance coverage checker	Not promoted	✅
Compounded options available	✅ Yes (separate program)	❌ Not Ro's lane
Two-month minimum	✅ Yes (on compounded)	❌ No
Membership fee	Starting at $125/mo (verify $99 vs $125 at checkout)	$39 first month, then $149/mo, or $74/mo annual prepay

Pick SHED if…

You want optional compounded under the same roof
You’re set on SHED specifically
You want Zepbound vial format specifically
One platform for everything matters more than the broadest menu

Pick Ro if…

You want the deepest FDA-approved lineup (including Zepbound pen and KwikPen)
You want help fighting your insurance
You want the lowest published cash-pay pricing locked in

See Ro’s GLP-1 program See SHED’s program

See our full head-to-head: SHED vs Ro (2026): Pricing, Meds, Honest Verdict.

What to ask SHED before you start

Answer capsule: The single most important question is: “Will my prescription be compounded or an FDA-approved brand-name medicine?” After that, ask about the dispensing pharmacy, the total monthly cost, the cancellation deadline, what happens if shipping is delayed, and what happens if the medicine doesn’t work or causes side effects. Screenshot anything important.

Medication questions

□ Is my prescription compounded or brand-name FDA-approved?
□ Which pharmacy or fulfillment partner is filling it?
□ If compounded, which compounding pharmacy?
□ If brand-name, is it coming from LillyDirect or NovoCare?

Cost questions

□ What is the medication cost?
□ Is there a Shed Membership / provider fee on top? Exactly how much — $99 or $125?
□ Is the price monthly, every 28 days, or per refill?
□ Does the price go up at higher doses?
□ What’s my first billing date? My second?

Cancellation questions

□ What’s my cancellation deadline?
□ Is there a minimum commitment?
□ What happens if I cancel mid-cycle?
□ Are there refund exceptions for side effects?

Logistics questions

□ How long does shipping take?
□ What happens if my medicine arrives warm or damaged?
□ Who do I contact for clinical questions?
□ What side effects should I report?

If any of these answers don’t make sense at checkout, don’t pay. Close the tab. Email customer service. Get clarity before money changes hands.

Pricing inconsistencies we caught on SHED’s own site

Compounded semaglutide injections: SHED’s product card lists compounded semaglutide injections starting at $299/month, while SHED’s weight-loss comparison table shows GLP-1 injections starting at $199/month. Verify your exact medication and dose at checkout.

Membership/provider fee: SHED’s Foundayo page lists Shed Membership starting at $125/month, while SHED’s Wegovy and Zepbound pages contain both $125 and $99 membership/provider-fee language in different sections. Confirm in writing before paying.

Frequently asked questions

Is SHED itself FDA-approved?: No, and that's not quite the right question. The FDA approves medicines, not telehealth platforms. SHED is a telehealth company that prescribes both FDA-approved medicines (Foundayo, Wegovy pill, Wegovy pen, Zepbound vial) and compounded medicines (which by definition are not FDA-approved). The accurate question is whether the specific SHED medicine you're considering is FDA-approved — and the product matrix earlier on this page answers that.
Does SHED offer Zepbound?: Yes. SHED currently lists Zepbound as an FDA-approved chronic weight-management option, with access to Zepbound in vial form when clinically approved. That's separate from SHED's compounded tirzepatide lane. Note that SHED's Zepbound pathway specifically lists vial access — not the Zepbound pen or Zepbound KwikPen formats. If you want the pen or KwikPen specifically, Ro is currently the more direct path.
Is compounded semaglutide FDA-approved?: No. By definition, compounded medicines aren't FDA-approved. The FDA's premarket review process applies to brand-name finished drug products like Wegovy and Ozempic. Compounded semaglutide is custom-prepared by a licensed pharmacy under a prescriber's order and doesn't go through that review. The FDA's own position is that compounded drugs should only be used when a patient's medical needs cannot be met by an FDA-approved drug.
Is SHED's compounded semaglutide the same as Ozempic or Wegovy?: No. Compounded semaglutide is prepared separately by compounding pharmacies and isn't the same finished product as Ozempic or Wegovy. We don't make "same active ingredient" or "generic" claims because the FDA has specifically warned companies not to market compounded GLP-1s that way — they're different regulatory categories of medicine.
Are SHED GLP-1 lozenges FDA-approved?: No. The lozenges are compounded sublingual semaglutide and aren't FDA-approved. The only FDA-approved oral semaglutide products are Rybelsus and the Wegovy pill, both of which went through specific clinical trials to establish absorption and efficacy. Compounded oral options have not been tested the same way.
Are SHED liquid GLP-1 drops FDA-approved?: No. Drops are compounded oral semaglutide or tirzepatide and aren't FDA-approved. Compounded oral semaglutide drops haven't gone through clinical trials that prove the same absorption or weight-loss effect as FDA-approved products.
Does SHED offer FDA-approved medications?: Yes. SHED currently lists FDA-approved Foundayo, Wegovy pill, Wegovy pen, and Zepbound (vial) through its brand-name pathway. Medicine is filled through LillyDirect or NovoCare. SHED's brand-name pathway is separate from its compounded program.
Can I use insurance with SHED?: Partially. The Shed Membership/provider fee is paid directly to SHED and is not covered by insurance. For FDA-approved brand-name GLP-1s (Foundayo, Wegovy, Zepbound vial), insurance may cover the medication through the dispensing pharmacy (LillyDirect or NovoCare) — verify with your insurer before committing. Compounded GLP-1s on SHED are cash-pay. HSA/FSA cards can be used for eligible prescription medication purchases. For more, see: Does SHED accept insurance.

What we actually verified

Last verified: May 16, 2026 by the Weight Loss Provider Guide editorial team.

Verified from public sources, May 16, 2026:

SHED’s current product lineup, by visiting tryshed.com product pages directly (compounded injections, drops, lozenges, liposomal tablets, microdose, Foundayo, Wegovy pill, Wegovy pen, Zepbound vial)
SHED’s stated FDA-status language on its product pages and help center
SHED’s April 14, 2026 Foundayo article
SHED’s two-month minimum and 72-hour cancellation window
FDA’s current position on compounded GLP-1s (“FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss”)
FDA’s April 30, 2026 proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulks List
Foundayo’s FDA approval (April 1, 2026)
Ro Body’s current pricing ($39 first month, $149/mo, or $74/mo annual prepay) and FDA-approved lineup via ro.co
Trustpilot rating (4.7 from 955 reviews) and BBB listing (not accredited, B rating)

What we couldn’t verify directly:

SHED’s exact 503A pharmacy partners for compounded products (this isn’t published and may vary by state). If your specific compounding pharmacy matters to you, ask SHED directly during your visit.
Specific insurance coverage outcomes for individual Wegovy or Zepbound prescriptions through SHED — that depends on your insurer, your plan, and prior authorization.

Next refresh: Monthly spot-check on pricing and lineup. Quarterly full refresh. Sooner if SHED’s lineup changes, FDA finalizes the 503B Bulks List proposal, or Ro’s pricing or lineup changes.

Ready to take the next step?

Start your SHED visit See Ro’s GLP-1 program Not sure? Take the 60-second quiz →